Information
-
Trademark
-
85807317
-
Serial Number
85807317
-
Registration Number
4586797
-
International Classifications
-
Filing Date
December 20, 2012
12 years ago
-
Registration Date
August 19, 2014
10 years ago
-
Transaction Date
May 04, 2021
3 years ago
-
Status Date
March 26, 2021
3 years ago
-
Published for Opposition Date
June 03, 2014
10 years ago
-
Location Date
August 19, 2014
10 years ago
-
Status Code
710
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
KUYKENDALL, LYNDSEY
-
Attorney Docket Number
60895-342376
Attorney Name
Mark Harrison
Law Office Assigned Location Code
L20
-
Owners
Mark Drawing Code
4000
Mark Identification
X-MAN
Case File Statements
- CC0000: Color is not claimed as a feature of the mark.
- GS0011: Human cells and isogenic cell lines for scientific, laboratory or medical research; genomic reference control samples for medical laboratory use; Molecular biology research tools, in the nature of biological and biochemical reagents, specifically, genomic DNA; DNA repair enzymes for scientific and research purposes; Biological and chemical reagents, namely, genomic DNA, cell cultures and mutant and normal isogenic human cell line pairs, for research use
- GS0051: Protein cell lysates. genomic DNA preparations and formalin fixed, paraffin embedded (FFPE) engineered tumor tissue mimics for medical diagnostic use
- GS0421: Custom cell-line engineering services; Scientific research in the field of genetics and genetic engineering, namely, gene-editing services, DNA modeling services, gene engineering services, establishing patient genotypes; Bio-technology, pharmaceutical and scientific testing, research and development services relating to genetics, and providing advice, consultancy and information services related thereto; biological research; pharmaceutical research services; drug discovery services; Scientific research and development services for lead identification and validation; Scientific research and development services for target identification and validation; Pharmaceutical research, namely, identification of patient-relevant drug targets, optimization of drug candidates for clinical development; Laboratory diagnostic services, namely, diagnosis of genetic mutations for clinical or research purposes and the design of molecular reference standards for assay development, clinical diagnostic quality control and proficiency schemes for the medical diagnostic services industry; medicinal research services, namely, hit discovery and hit to lead services; research and development services in the nature of creating libraries and collections of cells and cell lines, chemicals and compounds; research and development services in the nature of creating libraries and collections of normal and mutated genes; Scientific research and development services relating to targeting therapies to individuals; Scientific research and development services relating to combining therapies for individuals; research and development relating to reagents; Scientific research in the field of disease modeling; Medical and scientific research, namely, designing and conducting clinical trials for others; research and development in re-positioning existing drugs from other therapeutic indications
Case File Event Statements
-
3/26/2021 - 3 years ago
29 - CANCELLED SEC. 8 (6-YR)
Type: C8..
-
3/21/2017 - 7 years ago
28 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Type: CHAN
-
3/21/2017 - 7 years ago
27 - TEAS CHANGE OF OWNER ADDRESS RECEIVED
Type: COAR
-
8/19/2014 - 10 years ago
26 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
6/3/2014 - 10 years ago
25 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
5/14/2014 - 10 years ago
24 - NOTICE OF PUBLICATION
Type: NPUB
-
4/28/2014 - 10 years ago
23 - LAW OFFICE PUBLICATION REVIEW COMPLETED
Type: PREV
-
4/28/2014 - 10 years ago
22 - EXAMINERS AMENDMENT MAILED
Type: CNEA
-
4/25/2014 - 10 years ago
21 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
4/25/2014 - 10 years ago
20 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
4/25/2014 - 10 years ago
19 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
4/24/2014 - 10 years ago
18 - AMENDMENT FROM APPLICANT ENTERED
Type: ACEC
-
4/24/2014 - 10 years ago
17 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
4/15/2014 - 10 years ago
16 - PAPER RECEIVED
Type: MAIL
-
11/4/2013 - 11 years ago
15 - NON-FINAL ACTION MAILED
Type: CNRT
-
11/1/2013 - 11 years ago
14 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
10/17/2013 - 11 years ago
13 - AMENDMENT FROM APPLICANT ENTERED
Type: ACEC
-
10/17/2013 - 11 years ago
12 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
10/10/2013 - 11 years ago
11 - PAPER RECEIVED
Type: MAIL
-
4/11/2013 - 11 years ago
10 - COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Type: CEPE
-
4/11/2013 - 11 years ago
9 - EXAMINER'S AMENDMENT/PRIORITY ACTION MAILED
Type: CEAP
-
4/11/2013 - 11 years ago
8 - EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Type: CPEA
-
4/8/2013 - 11 years ago
7 - ASSIGNED TO EXAMINER
Type: DOCK
-
2/21/2013 - 12 years ago
6 - AMENDMENT FROM APPLICANT ENTERED
Type: ACEC
-
2/21/2013 - 12 years ago
5 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
2/13/2013 - 12 years ago
4 - ASSIGNED TO LIE
Type: ALIE
-
2/8/2013 - 12 years ago
3 - PAPER RECEIVED
Type: MAIL
-
1/8/2013 - 12 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Type: NWOS
-
12/24/2012 - 12 years ago
1 - NEW APPLICATION ENTERED IN TRAM
Type: NWAP